Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa

Sexually Transmitted Diseases

Volumn 33, Issue 10 SUPPL., 2006, Pages

  Vickerman, Peter ^a   Terris Prestholt, Fern ^a   Delany, Sinead ^b   Kumaranayake, Lilani ^a   Rees, Helen ^b   Watts, Charlotte ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MATHEMATICAL MODEL; POPULATION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA;

COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; PREVALENCE; PROSTITUTION; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT OUTCOME; URBAN POPULATION;

EID: 33748999993     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000221351.55097.36     Document Type: Article

References (69)

1. Department of Health. Summary report: National HIV and syphilis sero-prevalence survey of women attending public antenatal clinics in South Africa. 2001.
2. Pham Kanter GB, Steinberg MH, Ballard RC. Sexually transmitted diseases in South Africa. Genitourin Med 1996; 72:160-171.
3. Epidemiological Fact Sheets on HIV/AIDS and STIs for South Africa. Geneva: UNAIDS, 2002.
4. Shisana O, Simbayi L. Nelson Mandela/HSRC Study of HIV/AIDS. South African National HIV Prevalence, Behavioural Risks and Mass Media. Cape Town: The Human Sciences Research Council, 2002.
5. Gouws E, Williams BG, Sheppard HW, et al. High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immun Defic Syndr 2002; 29:531-535.
6. Ramkissoon A, Kleinschmidt I, Beksinka M, et al. National baseline assessment of sexually transmitted infection and HIV services in South African public sector health facilities. Available at: http:// www.rhru.co.za/site/ publications.asp. Durban: Reproductive Health Research Unit, 2004.
7. Eaton L, Flisher AJ, Aaro LE. Unsafe social behaviour in South African youth. Soc Sci Med 2003; 56:149-165.
8. Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS, 2002.
9. Williams BG, Taljaard D, Campbell CM, et al. Changing patterns of knowledge, reported behaviour and sexually transmitted infections in a South African gold mining community. AIDS 2003; 17:2099-2107.
10. Campbell C, Williams B. Beyond the biomedical and behavioural: Towards an integrated approach to HIV prevention in the southern African mining industry. Soc Sci Med 1999; 48:1625-1639.
11. Mathews C, Guttmacher SJ, Coetzee N, et al. Evaluation of a video based health education strategy to improve sexually transmitted disease partner notification in South Africa. Sex Transm Infect 2002; 78:53-57.
12. Morris CN, Cheevers EJ. A package of care for HIV in the occupational setting in Africa: Results of a pilot intervention. AIDS Patient Care STDs 2001; 15:633-640.
13. Harvey B, Stuart J, Swan T. Evaluation of a drama-in-education programme to increase AIDS awareness in South African high schools: A randomized community intervention trial. Int J STD AIDS 2000; 11:105-111.
14. Steen R, Vuylsteke B, DeCoito T, et al. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sex Transm Dis 2000; 27:1-8.
15. Kaul R, Kimani J, Nagelkerke N, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infections in Kenyan sex workers. JAMA 2004; 291:2555-2562.
16. Rees H, Beksinska M, Dickson-Tetteh K, et al. Commercial sex workers in Johannesburg: Risk behaviour and HIV status. South African Journal of Science 2000; 96:283-284.
17. Statistics South Africa. The People of South Africa: Population Census, 1996. Available at: http://www.statssa.gov.za/. 1996.
18. Fehler HG, Htun Y, Radebe F, et al. Patterns of genital tract infection among family planning clinic attenders and sex workers in South Africa (STDP 48). Lesedi STD Conference, 1999.
19. Pettifor A, Beksinska M, Rees H. High knowledge and high risk behaviour: A profile of hotel-based sex workers in inner-city Johannesburg. Afr J Reprod Health 2000; 4:35-43.
20. Dartnall E, Schneider H, Hlatshwayo Z, Clews F. STD Management in the Private Sector: A National Evaluation. Centre for Health Policy, 2000.
21. Moses S, Plummer FA, Ngugi N, et al. Controlling HIV in Africa: Effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS 1991; 5:407-411.
22. Protocols for the Management of a Person With a Sexually Transmitted Infection. Pretoria: Gauteng Directorate for AIDS and Communicable Diseases, 2001.
23. Kumaranayake L, Pepperall J, Goodman H, et al. Costing Guidelines for HIV/AIDS Prevention Strategies. UNAIDS Best Practice Collection-Key Materials. Geneva: UNAIDS, 1999.
24. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications and illustrations. In: Turner CF, Miller HG, Moses LE, ed. Confronting AIDS: Sexual Behaviour and Intravenous Drug Use. Washington, DC: National Academy Press, 1989:471-499.
25. Vickerman P, Watts CH. The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: Model predictions. International Journal of Drug Policy 2002; 13:149-164.
26. Rottingen J, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV. Sex Transm Dis 2001; 28:579-595.
27. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001; 17:901-910.
28. Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: A probabilistic empiric model. AIDS 2001; 15:621-627.
29. Pilcher CD, Tien H, Vernazza PL, et al. Semen viral dynamics in acute HIV infection: Implications for sexual transmission [Abstract ThOrC1489]. 14th International AIDS Conference, Barcelona, Spain, 2002.
30. Ballard R. HIV/RPR Surveillance Report Among STD Clinic Attenders. Johannesburg: South African Institute of Medical Research; 2000.
31. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: Is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16:597-603.
32. Maartens G, Wood R, O'Keefe E, Byrne C. Independent epidemics of heterosexual and homosexual HIV infection in South Africa - Survival differences. QJM 1997; 90:449-454.
33. Post FA, Badri M, Wood R, Maartens G. AIDS in Africa - Survival according to AIDS-defining illness. S Afr Med J 2001; 91:583-586.
34. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
35. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
36. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ 1992; 304:809-813.
37. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970; 91:170-174.
38. Lycke E, Lowhagen GB, Hallhagen G, et al. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980; 7:6-10.
39. Kretzschmar M, Welte R, van den Hoek A, Postma MJ. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153:90-101.
40. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. 1: The risk of gonorrhoea transmission from infected women to men. Am J Epidemiol 1978; 108:136-144.
41. Ruijs GJ, Schut IK, Schirm J, Schroder FP. Prevalence, incidence, and risk of acquiring urogenital gonococcal or chlamydial infection in prostitutes working in brothels. Am 1988; 64:49-51.
42. Quinn SC, Gaydos C, Shepherd ME, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737-1742.
43. World Population Datasheet. Washington DC: Population Reference Bureau, 2002.
44. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: An HIV model, as an example. International Statistical Review 1994; 62:229-243.
45. Fox-Rushby J, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost effectiveness analysis. Health Policy and Planning 2001; 16:326-331.
46. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Geneva: World Health Organization, 1996.
47. Rowley J, Berkley S. Sexually transmitted disease. In: Murray C, Lopez A, eds. Health Dimensions of Sex and Reproduction: The Global Burden of Sexually Transmitted Diseases, HIV, Maternal Conditions, Perinatal Disorders, and Congenital Anomalies. Geneva: World Health Organization, 1998.
48. World Development Report 1993: Investing in Health. New York: Oxford University Press for the World Bank, 1993.
49. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: A systematic review of the evidence. Lancet 2002; 359:1635-1643.
50. Soderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: Analysis of cost effectiveness of options available in South Africa. BMJ 1999; 318:1650-1656.
51. Wood E, Braitstein P, Montaner JSG, et al. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000; 355:2095.
52. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomised controlled trial. Lancet 1995; 346:530-536.
53. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002; 13:91-101.
54. Hanschell HM. Sulphanilamide in the treatment of chancroid. Lancet 1938; 1:886-888.
55. Garnett GP, Aral SO, Hoyle DV, et al. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 1997; 24:185-200.
56. Morgan D, Mahe C, Mayanja B, Whitworth JAG. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: Prospective cohort study. BMJ 2002; 324:193-196.
57. Mann JR, Stine CC, Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom. Sex Transm Dis 2002; 29:344-349.
58. Korenromp EL, Sake JDV, Nagelkerke N, Habbema JD. Estimating the magnitude of STD cofactor effects on HIV transmission. Sex Transm Dis 2001; 28:613-621.
59. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44:1303-1312.
60. Pinkerton SD, Abramson PR, Turk ME. Updated estimates of condom effectiveness. J Assoc Nurses AIDS Care 1998; 9:88-89.
61. Seven Buildings Project. Hillbrow Community Profile. Johannesburg: Reproductive Health Research Unit, 1994.
62. Hawkes S, West B, Wilson S, et al. Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction. Genitourin Med 1995; 71:224-227.
63. Blankhart D, Muller O, Gresenguet G, Weis P. Sexually transmitted infections in young pregnant women in Bangui, Central African Republic. Int J STD AIDS 1999; 10:609-614.
64. O'Farrel N, Hoosen AA, Coetzee KD, van den Ende J. Genital ulcer disease: Accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourin Med 1994; 70:7-11.
65. Waugh MA. Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women. J Antimicrob Chemother 1993; 31(suppl E):193-198.
66. Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21:43-46.
67. Ballard RC, Ye H, Matta A, et al. Treatment of chancroid with azithromycin. Int J STD AIDS 1996; 7(suppl 1):9-12.
68. Martin DH, Sargent SJ, Wendel GD Jr, et al. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 1995; 21:409-414.
69. Hook EW 3rd, Martin DH, Stephens J, et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29:486-490.